Publicacions destacades

• Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection

  Fuster-Anglada, C; Mauro, E; Ferrer-Fàbrega, J; Caballol, B; Sanduzzi-Zamparelli, M;

  Bruix, J; Fuster, J; Reig, M; Díaz, A; Forner, A.

  Referència:

  Journal Of Hepatology 2024.

• Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus

  Yanagihara, Ted K; Tepper, Joel E; Moon, Andrew M; Barry, Aisling; Molla, Meritxell;

  (...)

  Wo, Jennifer Y; Yoon, Sang Min; Lawrence, Theodore S; Reig, Maria; Dawson, Laura A.

  Veure llistat complet d'autors

  Referència:

  Practical Radiation Oncology 2024.

• Reliability of extracellular contrast versus gadoxetic acid in assessing small liver lesions using liver imaging reporting and data system v.2018 and European association for the study of the liver criteria

  Rimola, J; Sapena, V; Brancatelli, G; Darnell, A; Forzenigo, L;

  (...)

  Wagner, M; Ayuso, C; Vilgrain, V; Reig, M; Ronot, M.

  Veure llistat complet d'autors

  Referència:

  Hepatology 2022.

• Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules

  Sanduzzi-Zamparelli, Marco; Marino, Zoe; Lens, Sabela; Sapena, Victor; Iserte, Gemma;

  (...)

  Forner, Alejandro; Torres, Ferran; Bruix, Jordi; Forns, Xavier; Reig, Maria.

  Veure llistat complet d'autors

  Referència:

  Journal Of Hepatology 2022.

• BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

  Reig, M; Forner, A; Rimola, J; Ferrer-Fàbrega, J; Burrel, M;

  (...)

  Singal, AG; Vogel, A; Fuster, J; Ayuso, C; Bruix, J.

  Veure llistat complet d'autors

  Referència:

  Journal Of Hepatology 2022.

• Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis

  Sapena, Victor; Enea, Marco; Torres, Ferran; Celsa, Ciro; Rios, Jose;

  (...)

  Trevisani, Franco; Camma, Calogero; Bruix, Jordi; Cabibbo, Giuseppe; Reig, Maria.

  Veure llistat complet d'autors

  Referència:

  Gut 2022.

• Regorafenib efficacy after sorafenib in patients with recurrent HCC after liver transplantation: a retrospective study

  Iavarone, M; Invernizzi, F; Mazza, S; Donato, MF; Lampertico, P;

  (...)

  Soteras, GA; Villadsen, GE; Crespo, G; Prince, R; Scudeller, L.

  Veure llistat complet d'autors

  Referència:

  Liver Transplantation 2021.

• Limited tumor progression beyond Milan criteria while on the waiting list does not result in unacceptable impairment of survival

  Ferrer-Fabrega, Joana; Sampson-Davila, Jaime; Forner, Alejandro; Sapena, Victor; Diaz, Alba;

  (...)

  Ayuso, Carmen; Garcia-Valdecasas, Juan Carlos; Bruix, Jordi; Reig, Maria; Fuster, Josep.

  Veure llistat complet d'autors

  Referència:

  Journal Of Hepatology 2021.

• Antiviral therapy in the palliative setting of HCC (BCLC B and C)

  Reig, M; Cabibbo, G;

  Referència:

  Journal Of Hepatology 2021.

• Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma

  Corominas, Josep; Sapena, Victor; Sanduzzi-Zamparelli, Marco; Millan, Cristina; Samper, Esther;

  (...)

  Munoz-Martinez, Sergio; Forner, Alejandro; Bruix, Jordi; Boix, Loreto; Reig, Maria.

  Veure llistat complet d'autors

  Referència:

  Cancers 2021.